Occluded vein as a predictor for complications in non-infectious transvenous lead extraction.
complications
non-infectious
occluded vein
transvenous lead extraction
venography
Journal
Frontiers in cardiovascular medicine
ISSN: 2297-055X
Titre abrégé: Front Cardiovasc Med
Pays: Switzerland
ID NLM: 101653388
Informations de publication
Date de publication:
2022
2022
Historique:
received:
11
08
2022
accepted:
13
09
2022
entrez:
31
10
2022
pubmed:
1
11
2022
medline:
1
11
2022
Statut:
epublish
Résumé
The use of cardiovascular implantable electronic device (CIED) is steadily increasing, and complications include venous occlusion and fractured leads. Transvenous lead extraction (TLE) can facilitate the re-implantation of new leads. This study aims to explore predictors and complications of non-infectious TLE. This study involves a retrospective analysis and comparison of characteristics, complications, and outcomes of patients with and without occluded veins (OVs) undergoing TLE at our center. In total, eighty-eight patients underwent TLE for non-infectious reasons. Indications for TLE were lead malfunction (62; 70.5%) and need for CIED upgrade (22; 25%). Fourteen patients referred due to lead malfunction had an OV observed during venography. The OV group (36 patients) were significantly older (65.7 ± 14.1 vs. 53.8 ± 15.9, Among the TLE for non-infectious reasons, vein occlusion appears as a major predictor of complex TLE tool use, complications, and procedural success. Venography should be considered prior to non-infectious TLE to identify high-risk patients.
Sections du résumé
Background
UNASSIGNED
The use of cardiovascular implantable electronic device (CIED) is steadily increasing, and complications include venous occlusion and fractured leads. Transvenous lead extraction (TLE) can facilitate the re-implantation of new leads.
Aims
UNASSIGNED
This study aims to explore predictors and complications of non-infectious TLE.
Methods
UNASSIGNED
This study involves a retrospective analysis and comparison of characteristics, complications, and outcomes of patients with and without occluded veins (OVs) undergoing TLE at our center.
Results
UNASSIGNED
In total, eighty-eight patients underwent TLE for non-infectious reasons. Indications for TLE were lead malfunction (62; 70.5%) and need for CIED upgrade (22; 25%). Fourteen patients referred due to lead malfunction had an OV observed during venography. The OV group (36 patients) were significantly older (65.7 ± 14.1 vs. 53.8 ± 15.9,
Conclusion
UNASSIGNED
Among the TLE for non-infectious reasons, vein occlusion appears as a major predictor of complex TLE tool use, complications, and procedural success. Venography should be considered prior to non-infectious TLE to identify high-risk patients.
Identifiants
pubmed: 36312249
doi: 10.3389/fcvm.2022.1016657
pmc: PMC9601735
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1016657Informations de copyright
Copyright © 2022 Milman, Leshem, Massalha, Jia, Meitus, Kariv, Shafir, Glikson, Luria, Sabbag, Beinart and Nof.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
J Cardiovasc Electrophysiol. 2004 Nov;15(11):1258-62
pubmed: 15574174
Acta Cardiol. 2017 Feb;72(1):61-67
pubmed: 28597736
Heart Rhythm. 2017 Dec;14(12):e503-e551
pubmed: 28919379
Circulation. 2007 May 15;115(19):2461-3
pubmed: 17502585
Heart Rhythm. 2021 Sep;18(9):1566-1576
pubmed: 33984526
Heart Rhythm. 2015 Jun;12(6):1177-82
pubmed: 25661776
J Am Coll Cardiol. 2010 Feb 9;55(6):579-86
pubmed: 20152562
Europace. 2014 Sep;16(9):1350-5
pubmed: 24554523
Pacing Clin Electrophysiol. 2003 Aug;26(8):1649-52
pubmed: 12877695
Eur Heart J. 2017 Oct 21;38(40):2995-3005
pubmed: 28369414
Heart Rhythm. 2022 Jul;19(7):1097-1103
pubmed: 34695576
Europace. 2016 Aug;18(8):1220-6
pubmed: 26705557
Circulation. 2006 May 23;113(20):2391-7
pubmed: 16702467
PLoS One. 2019 Apr 29;14(4):e0215589
pubmed: 31034499
Rofo. 2015 Nov;187(11):1029-35
pubmed: 26200569
J Cardiovasc Electrophysiol. 2020 May;31(5):1155-1162
pubmed: 32141635
J Am Heart Assoc. 2015 Oct 30;4(11):
pubmed: 26518666
J Cardiovasc Electrophysiol. 2021 Feb;32(2):491-499
pubmed: 33345428
Europace. 2018 Jul 1;20(7):1217
pubmed: 29566158
Europace. 2014 Dec;16(12):1795-9
pubmed: 24948591